TotalEnergies' SATORP refinery in Saudi Arabia is operating at reduced capacity after drone attacks. Full repairs are expected by early 202...

The conditions that created the worst 18 months for small-caps are starting to ease. The US-Iran war is moving towards settlement. Crude pr...

Indian investors are increasingly seeking global investments. Wealth managers emphasize strategic diversification, not reactive choices. De...

A peace deal, if it comes, will not mean the Gulf region has become stable. It will only mean that current tensions have been paused. The k...

India's top three smallcap mutual funds, managing over Rs 1.5 lakh crore, show strong consensus by holding five under-the-radar stocks acro...

The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) is expanding healthcare access, with 6 crore senior citizens enrolled and o...

Indian equities offer rare discounts for investors. Nippon India Mutual Fund's Equity CIO, Sailesh Raj Bhan, advises accumulating world-cla...

India's health sector has seen historic changes in the last 12 years. Accessible, affordable, and quality healthcare is now a reality for c...

Prime Minister Narendra Modi said India has made healthcare more affordable and accessible over the past 12 years through initiatives such ...

Elon Musk, the world's richest man, leads a sprawling business empire. His ventures include electric vehicles, brain implants, underground ...

India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...

India's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...

Belligerence is back. Both the US and Iran are hitting each other and the statements from both sides do not auger well for a peace deal. Th...

India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...

When mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...

India's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...